4d • General discussion
Shifting Gears: Moving from Regenerative Peptides to Pure Anti-Inflammatories (Pre-Op Transition)
Hey everyone, wanted to share a quick update on my journey and get some insight into my next stack.
For the past couple of years, I’ve been battling severe chronic inflammation, specifically dealing with uveitis (eye inflammation). For the past 6 weeks I’ve been running a cycle of ARA-290, BPC-157, TB-500, and Semax, and honestly, it has done wonders.
The uveitis has significantly regressed, and the persistent inflammation I’ve struggled with for two years has completely gone. I also strongly believe ARA-290 is going to be a massive help for my glaucoma moving forward.
However, I have a presoflow surgery coming up soon. Because of this, I need to completely shift away from regenerative peptides (like BPC and TB-500), as their tissue-growing and angiogenic properties are not conducive to the healing environment required for this specific surgery.
I am transitioning strictly to purely anti-inflammatory and immunomodulatory compounds. I'm looking into purchasing and gathering real-world feedback on this new protocol:
- KPV (10 mg)
- Selank (5 mg)
- Thymosin Alpha-1
Has anyone here transitioned to a similar stack pre-surgery? I'd love to hear your experiences with sourcing, dosing, or how these specific compounds handled systemic inflammation without interfering with surgical healing. Thanks!
1
0 comments
Shifting Gears: Moving from Regenerative Peptides to Pure Anti-Inflammatories (Pre-Op Transition)
powered by
skool.com/advanced-peptide-research-5972
Advanced Peptide Research is a community focused on peptide education, biohacking, recovery, wellness, and human optimization.
Suggested communities
Powered by